This presentation explores the role of neuroimaging biomarkers in the early detection and diagnosis of Alzheimer's disease. We discuss advanced imaging techniques such as PET-CT, MRI, and amyloid imaging, and their utility in identifying preclinical and prodromal stages of Alzheimer's disease.

This presentation reviews emerging therapies for multiple sclerosis (MS), focusing on novel treatment approaches beyond disease-modifying agents. We discuss the potential of remyelination strategies, neuroprotective therapies, and immune-modulating agents in slowing disease progression and improving clinical outcomes for MS patients.